» Authors » Jennette A Sakoff

Jennette A Sakoff

Explore the profile of Jennette A Sakoff including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 69
Citations 798
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Baker J, Gilbert J, OBrien N, Russell C, McCluskey A, Sakoff J
Front Chem . 2024 Jul; 12:1396105. PMID: 38974991
We previously reported on the interaction of 10-chloro-7-benzo[]benzo[4,5]imidazo[2,1-]isoquinolin-7-one (10-Cl-BBQ) with the Aryl hydrocarbon Receptor (AhR) and selective growth inhibition in breast cancer cell lines. We now report on a library...
2.
Prichard K, Chau N, Xue J, Krauss M, Sakoff J, Gilbert J, et al.
ChemMedChem . 2024 Jun; 19(20):e202400253. PMID: 38894585
Twenty-five chimera compounds of Pitstop 1 and 2 were synthesised and screened for their ability to block the clathrin terminal domain-amphiphysin protein-protein interaction (NTD-PPI using an ELISA) and clathrin mediated...
3.
OBrien N, Gilbert J, McCluskey A, Sakoff J
RSC Med Chem . 2024 May; 15(5):1686-1708. PMID: 38784470
Tubulin plays a central role in mitosis and has been the target of multiple anticancer drugs, including paclitaxel. Herein two separate families of 2,3-dihydroquinazoline-4(1)-ones and quinazoline-4(3) ones, comprising 57 compounds...
4.
Aputen A, Elias M, Gilbert J, Sakoff J, Gordon C, Scott K, et al.
Int J Mol Sci . 2024 Feb; 25(4). PMID: 38396859
Kinetically inert platinum(IV) complexes are a chemical strategy to overcome the impediments of standard platinum(II) antineoplastic drugs like cisplatin, oxaliplatin and carboplatin. In this study, we reported the syntheses and...
5.
Sun J, Baker J, Russell C, Pham H, Goldsmith C, Cossar P, et al.
RSC Med Chem . 2023 Nov; 14(11):2246-2267. PMID: 37974967
From lead 1, (-(4-((4-(3-(4-(3-methoxyphenyl)-1-1,2,3-triazol-1-yl)propyl)piperazin-1-yl)sulfonyl)-phenyl)acetamide), a S100A2-p53 protein-protein interaction inhibitor based on an modelling driven hypothesis, four focused libraries were designed and synthesised. Growth inhibition screening was performed against 16 human...
6.
Aputen A, Elias M, Gilbert J, Sakoff J, Gordon C, Scott K, et al.
Cancers (Basel) . 2023 May; 15(9). PMID: 37173934
Developing new and versatile platinum(IV) complexes that incorporate bioactive moieties is a rapidly evolving research strategy for cancer drug discovery. In this study, six platinum(IV) complexes (-) that are mono-substituted...
7.
Khoury A, Sakoff J, Gilbert J, Karan S, Gordon C, Aldrich-Wright J
Pharmaceutics . 2022 Dec; 14(12). PMID: 36559273
Four platinum(IV) prodrugs incorporating a biotin moiety to selectively target cancer cells were synthesised, characterised, and their biological activity assessed. All complexes exhibited exceptional in vitro cytotoxicity against a panel...
8.
Khoury A, Elias E, Mehanna S, Shebaby W, Deo K, Mansour N, et al.
J Med Chem . 2022 Dec; 65(24):16481-16493. PMID: 36480933
A novel platinum(II) complex and its platinum(IV) derivative were synthesized and characterized. Cytotoxicity studies against mesenchymal cells (MCs) and lung (A549), breast (MDA-MB-231), and melanoma (A375) cancer cells demonstrated 7-20-fold...
9.
Aputen A, Elias M, Gilbert J, Sakoff J, Gordon C, Scott K, et al.
Molecules . 2022 Oct; 27(20). PMID: 36296713
A new series of cytotoxic platinum(IV) complexes (-) incorporating halogenated phenylacetic acid derivatives (4-chlorophenylacetic acid, 4-fluorophenylacetic acid, 4-bromophenylacetic acid and 4-iodophenylacetic acid) were synthesised and characterised using spectroscopic and spectrometric...
10.
Aputen A, Elias M, Gilbert J, Sakoff J, Gordon C, Scott K, et al.
Int J Mol Sci . 2022 Sep; 23(18). PMID: 36142383
The DNA-alkylating derivative chlorambucil was coordinated in the axial position to atypical cytotoxic, heterocyclic, and non-DNA coordinating platinum(IV) complexes of type, (where H is 1,10-phenanthroline, 5-methyl-1,10-phenanthroline or 5,6-dimethyl-1,10-phenanthroline, A is...